Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

A mutation in the human hairless gene causes alopecia universalis.

The document suggests a rare skin condition might be caused by a genetic phenomenon.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

An 8-year-old boy with Recklinghausen's Disease shows various symptoms and is from a family with close genetic ties.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

A mutation in the hairless gene speeds up severe itchy skin in mice on a special diet.

HSD11b1 affects skin nerves and increases non-histaminergic itch.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

ILC1 cells contribute to hair loss in alopecia areata.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

The hairless gene in Kunming mice is important for hair and skin, and shows genetic variations.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.